#geffen

Ep. 48 - House of 1000 Corpses (Farmer is back!)

Windy

Promoting GN'R (Peter Napoliello Part 2) | Ep. 311

Figure Eights (A Music Podcast) - Episode 41 w_ Ted Niceley (Producer: Fugazi, Jawbox, Shudder to Think, Tommy Keene, Girls Against Boys)

Blink-182 (2003)

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 8: The Biomarkers France Study (audio)

ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (audio)

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 8: The Biomarkers France Study (video)

How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?

ASCO Lung Cancer Highlights, Part 9: The MADeIT Study of Predictive Biomarkers for Chemotherapy in Advanced NSCLC (video)

ASCO Lung Cancer Highlights, Part 9: The MADeIT Study of Predictive Biomarkers for Chemotherapy in Advanced NSCLC (audio)

MK-3475 and its Efficacy in Lung Cancer

Peter Napoliello talks Geffen & the rise of Appetite for Destruction | Ep. 144

Roundabout Roundup: SnapTravel, Broadway Podcasts, and 1010!

entertainment publicist Jo-Ann Geffen